Shantanu Banerji

Shantanu Banerji

UNVERIFIED PROFILE

Are you Shantanu Banerji?   Register this Author

Register author
Shantanu Banerji

Shantanu Banerji

Publications by authors named "Shantanu Banerji"

Are you Shantanu Banerji?   Register this Author

19Publications

752Reads

14Profile Views

Benefit of crizotinib in a lung cancer patient with discordant ALK testing results.

Cancer Treat Res Commun 2018 21;15:13-16. Epub 2018 Feb 21.

Rady Faculty of Health Sciences, Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada; Cancer Care Manitoba, Department of Hematology and Medical Oncology, Winnipeg, MB, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2018.02.002DOI Listing
June 2019

Patient Reported Outcomes Following Lower Extremity Soft Tissue Sarcoma Resection with Microsurgical Preservation of Ambulation.

J Reconstr Microsurg 2019 Mar 18;35(3):168-175. Epub 2018 Aug 18.

Department of Surgery, Section of Plastic Surgery, University of Manitoba, Winnipeg, MB, Canada.

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1668116
Publisher Site
http://dx.doi.org/10.1055/s-0038-1668116DOI Listing
March 2019

Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer.

Horm Cancer 2018 08 18;9(4):288-294. Epub 2018 Jun 18.

Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12672-018-0336-7
Publisher Site
http://dx.doi.org/10.1007/s12672-018-0336-7DOI Listing
August 2018

Immune Signatures of Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 06;12(6):913-915

Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada and Department of Medical Oncology, CancerCare Manitoba, Winnipeg, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.04.008DOI Listing
June 2017

A 16 Yin Yang gene expression ratio signature for ER+/node- breast cancer.

Int J Cancer 2017 03;140(6):1413-1424

Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.30556DOI Listing
March 2017

A 10-Gene Yin Yang Expression Ratio Signature for Stage IA and IB Non-Small Cell Lung Cancer.

J Thorac Oncol 2016 12 4;11(12):2150-2160. Epub 2016 Aug 4.

Research Institute of Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; Section of Hematology and Oncology, Department of Internal Medicine, Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.023DOI Listing
December 2016

Phase II study of PX-866 in recurrent glioblastoma.

Neuro Oncol 2015 Sep 20;17(9):1270-4. Epub 2015 Jan 20.

CancerCare Manitoba, Winnipeg, Canada (M.W.P., S.B.); Queen's University, Department of Oncology, Kingston, Canada (E.A.E.); Dalhousie University,Halifax, Canada (M.V.M.); BritishColumbia Cancer Agency, Vancouver, Canada (B.T.); Tom Baker Cancer Centre, Calgary, Canada (J.C.E.); London Regional Cancer Program, London, Canada (D.R.M.); University of Alberta, Edmonton, Canada (D.D.E.); Allan Blair Cancer Center, Regina, Canada (A.S.K., M.S., H.C.); Department of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (J.S.); Department of Pathology, University Health Network, University of Toronto, Toronto, Canada (M.S.T., S.K.-R.); NCIC Clinical Trials Group, Queen's University, Kingston, Canada (D.T., J.P.); Oncothyreon, Inc., Seattle, Washington (D.F.H.); Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada (W.P.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588751PMC
September 2015

Pugh et al. reply.

Nature 2015 Apr;520(7547):E12-4

1] Department of Medical Oncology and Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA [2] Cancer Program, Broad Institute, Cambridge, Massachusetts, 02142, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature14266DOI Listing
April 2015

Yin Yang gene expression ratio signature for lung cancer prognosis.

PLoS One 2013 17;8(7):e68742. Epub 2013 Jul 17.

Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0068742PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714286PMC
March 2014

Molecular pathways: PI3K pathway targets in triple-negative breast cancers.

Clin Cancer Res 2013 Jul 7;19(14):3738-44. Epub 2013 Jun 7.

Department of Medical Oncology, CancerCare Manitoba, Manitoba, Winnipeg, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-0274DOI Listing
July 2013

Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.

Nat Genet 2012 Oct 2;44(10):1104-10. Epub 2012 Sep 2.

Department of Translational Genomics, University of Cologne, Cologne, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2396DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915822PMC
October 2012

Important differences between topoisomerase-I and -II targeting agents.

Cancer Biol Ther 2006 Aug 14;5(8):965-6. Epub 2006 Aug 14.

Manitoba Institute of Cell Biology, Winnipeg, Manitoba, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.5.8.3274DOI Listing
August 2006